Three Treatments for EGFR-Mutant Non-Small-Cell Lung Cancer with Brain Metastases

被引：0
作者：
Fan, Y. [1 ]
Yu, X. [2 ]
Wang, H. [2 ]
机构：
[1] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Thorac Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Epidermal growth factor receptor; Tyrosine kinase inhibitors; brain metastases;
D O I：
10.1016/j.jtho.2017.09.1510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-069
引用
收藏
页码：S2228 / S2228
页数：1
相关论文
共 50 条
[31]   Histologic transformation of non-small-cell lung cancer in brain metastases [J].
Meng Jiang ;
Xiaolong Zhu ;
Xiao Han ;
Haiyan Jing ;
Tao Han ;
Qiang Li ;
Xiao Ding .
International Journal of Clinical Oncology, 2019, 24 :375-384
[32]   Histologic transformation of non-small-cell lung cancer in brain metastases [J].
Jiang, Meng ;
Zhu, Xiaolong ;
Han, Xiao ;
Jing, Haiyan ;
Han, Tao ;
Li, Qiang ;
Ding, Xiao .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (04) :375-384
[33]   High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases [J].
Ge, Mengxi ;
Zhuang, Yingjie ;
Zhou, Xinli ;
Huang, Ruofan ;
Liang, Xiaohua ;
Zhan, Qiong .
JOURNAL OF NEURO-ONCOLOGY, 2017, 135 (02) :413-418
[34]   Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis [J].
Wen, Lei ;
Zhen, Junjie ;
Shan, Changguo ;
Lai, Mingyao ;
Hong, Weiping ;
Wang, Hui ;
Ye, Mingting ;
Yang, Yanying ;
Li, Shaoqun ;
Zhou, Zhaoming ;
Zhou, Jiangfen ;
Hu, Qingjun ;
Li, Juan ;
Tian, Xuwei ;
Chen, Longhua ;
Cai, Linbo ;
Xie, Zhanhong ;
Zhou, Cheng .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
[35]   Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients [J].
Fan, Yun ;
Huang, Zhiyu ;
Fang, Luo ;
Miu, Lulu ;
Lin, Nengming ;
Gong, Lei ;
Yu, Haifeng ;
Yang, Haiyan ;
Mao, Weimin .
ONCOTARGETS AND THERAPY, 2013, 6 :1789-1802
[36]   ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer [J].
Ana Ortega-Franco ;
Shereen Rafee .
Oncology and Therapy, 2022, 10 :13-22
[37]   ADAURA: The Splash of Osimertinib in Adjuvant EGFR-Mutant Non-small Cell Lung Cancer [J].
Ortega-Franco, Ana ;
Rafee, Shereen .
ONCOLOGY AND THERAPY, 2022, 10 (01) :13-22
[38]   Therapeutic strategy for advanced EGFR mutant non-small-cell lung carcinoma [J].
Cadranel, Jacques ;
Ruppert, Anne-Marie ;
Beau-Faller, Michele ;
Wislez, Marie .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (03) :477-493
[39]   How to develop novel treatments for EGFR-mutant lung cancer [J].
Banna, Giuseppe Luigi ;
Tiseo, Marcello .
FUTURE ONCOLOGY, 2015, 11 (17) :2375-2378
[40]   Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib [J].
Kim, Youjin ;
Lee, Se-Hoon ;
Ahn, Jin Seok ;
Ahn, Myung-Ju ;
Park, Keunchil ;
Sun, Jong-Mu .
CANCER RESEARCH AND TREATMENT, 2019, 51 (02) :502-509
12345